A groundbreaking solution for presbyopia, the age-related difficulty in seeing up close, has finally arrived. The FDA has approved VIZZ, the first aceclidine-based eye drop designed to restore near vision for up to 10 hours, offering relief without the need for glasses. This once-daily treatment works differently from older drops, promising clear vision with minimal side effects.
Click on to discover how VIZZ works, its benefits, what presbyopia is, and why it could be a game-changer for millions.